Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06644989 · ClinicalTrials.gov registry record · NA

Impact of Osteopathic Manipulative Therapy on Hip Range of Motion

A NA study, sponsored by Lake Erie College of Osteopathic Medicine.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT06644989 is a NA study that has completed, run by Lake Erie College of Osteopathic Medicine. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06644989, a NA study, has completed, sponsored by Lake Erie College of Osteopathic Medicine.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

One way for runners to improve their performance and remain injury free is to preserve and improve joint mobility, especially at the hips. The femoroacetabular joints are a pivotal part of the running gait allowing the athlete to fully extend their leg to generate sufficient force in each stride. Improving hip range of motion can help reduce or prevent groin pain, make the runner more comfortable while running, improve running longevity, and prevent injuries. Thus, it is clear that a runner's commitment to improving the range of motion of their hips is crucial for both the enhancement of their performance and prevention of injury. Researchers assessed how the hip, and its biomechanics, can be impacted by Osteopathic medical treatment. The primary research question investigated is how Spencer Technique for the hip impacts femoral acetabular active range of motion (AROM) in flexion, extension, abduction, adduction, internal rotation, and external rotation in those training 4 weeks for a 5K race. This study investigated the effect that 4 weeks of twice weekly, bilateral, Spencer Technique treatment had on femoroacetabular range of motion. During this 4-week period participant exercise and stretching habits in preparation for the 5k race were recorded.

Interventions

  • OTHER Sham (No Treatment)
  • PROCEDURE Spencer Technique

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-01-01
Est. Completion 2024-02-29
Phase NA

What the Registry Record Tells You About NCT06644989

The ClinicalTrials.gov registry entry for NCT06644989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lake Erie College of Osteopathic Medicine, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sham (No Treatment) is the first listed.

NCT06644989 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06644989 about?

NCT06644989 is a clinical study titled "Impact of Osteopathic Manipulative Therapy on Hip Range of Motion". One way for runners to improve their performance and remain injury free is to preserve and improve joint mobility, especially at the hips. The femoroacetabular joints are a pivotal part of the running gait allowing the athlete to fully extend their leg to generate sufficient force in each stride. Im...

What is the current status of trial NCT06644989?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-01-01. Estimated completion is 2024-02-29.

What interventions are being tested in trial NCT06644989?

The interventions under investigation include: Sham (No Treatment) (OTHER), Spencer Technique (PROCEDURE).

Who is sponsoring clinical trial NCT06644989?

This trial is sponsored by Lake Erie College of Osteopathic Medicine, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.